The Cigna Group (NYSE:CI) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

The Cigna Group (NYSE:CI - Get Free Report) had its price objective boosted by equities research analysts at Cantor Fitzgerald from $350.00 to $365.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an "overweight" rating on the health services provider's stock. Cantor Fitzgerald's price target points to a potential upside of 13.78% from the company's previous close.

A number of other analysts have also recently commented on CI. Royal Bank of Canada set a $355.00 price target on The Cigna Group in a research note on Friday, January 31st. Stephens cut their target price on shares of The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. StockNews.com raised shares of The Cigna Group from a "hold" rating to a "buy" rating in a research report on Wednesday, February 19th. Barclays lowered their price objective on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Finally, Piper Sandler reiterated an "overweight" rating and set a $348.00 target price (down from $394.00) on shares of The Cigna Group in a report on Monday, February 3rd. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, The Cigna Group currently has an average rating of "Buy" and a consensus price target of $373.25.

Remove Ads

The Cigna Group Trading Up 1.3 %

Shares of CI traded up $4.14 on Thursday, reaching $320.79. 1,287,842 shares of the company's stock were exchanged, compared to its average volume of 1,565,016. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The stock has a market capitalization of $87.79 billion, a P/E ratio of 26.21, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The business has a 50 day moving average price of $301.62 and a two-hundred day moving average price of $314.45.

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the company posted $6.79 earnings per share. Research analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Nicole S. Jones sold 4,904 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. This represents a 14.29 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,751 shares of company stock worth $13,603,991. Insiders own 0.60% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CI. TCTC Holdings LLC bought a new position in The Cigna Group during the fourth quarter worth about $25,000. Collier Financial bought a new position in shares of The Cigna Group during the 4th quarter worth approximately $32,000. ORG Wealth Partners LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth approximately $34,000. Putney Financial Group LLC bought a new stake in The Cigna Group in the 4th quarter valued at $36,000. Finally, Prospera Private Wealth LLC bought a new stake in The Cigna Group in the 3rd quarter valued at $37,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.